Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Spatio-temporal model of Meox1 expression control involvement of Sca-1-positive stem cells in neointima formation through the synergistic effect of Rho/CDC42 and SDF-1α/CXCR4

View through CrossRef
Abstract Aims Neointimal hyperplasia remains a major obstacle in vascular regeneration. Sca-1-positive progenitor cells residing within the vascular adventitia play a crucial role in the assemblage of vascular smooth muscle cell (VSMC) and the formation of the intimal lesion. However, the underlying mechanisms during vascular injury are still unknown. Methods and results Aneointimal formation rat model was prepared by carotid artery injury using 2F-Forgaty. After vascular injury, Meox1 expressions time-dependently increased during the neointima formation, with its levels concurrently increasing in the adventitia, media, and neointima. Meox1 was highly expressed in the adventitia on the first day after vascular injury compared to the expression levels in the media. Conversely, by the 14th day post-injury, Meox1 was extensively expressed more in the media and neointima than the adventitia. Analogous to the change of Meox1 in injured artery, Sca-1+ progenitor cells increased in the adventitia wall in a time-dependent manner and reached peak levels on the 7th day after injury. More importantly, this effect was abolished by Meox1 knockdown with shRNA. The enhanced expression of SDF-1α after vascular injury was associated with the markedly enhanced expression levels of Sca1+ progenitor cell, and these levels were relatively synchronously increased within neointima by the 7th day after vascular injury. These special effects were abolished by the knockdown of Meox1 with shRNA and inhibition of CXCR4 by its inhibitor, AMD3100. Finally, Meox1 concurrently regulated SDF-1α expressions in VSMC via activating CDC42, and CDC42 inhibition abolished these effects by its inhibitor, ZCL278. Also, Meox1 was involved in activation of the CXCR4 expression of Sca-1+ progenitor cells by CDC42. Conclusions Spatio-temporal model of Meox1 expression regulates theSca-1+progenitor cell migration during the formation of the neointima through the synergistic effect of Rho/CDC42 and SDF-1α/CXCR4.
Title: Spatio-temporal model of Meox1 expression control involvement of Sca-1-positive stem cells in neointima formation through the synergistic effect of Rho/CDC42 and SDF-1α/CXCR4
Description:
Abstract Aims Neointimal hyperplasia remains a major obstacle in vascular regeneration.
Sca-1-positive progenitor cells residing within the vascular adventitia play a crucial role in the assemblage of vascular smooth muscle cell (VSMC) and the formation of the intimal lesion.
However, the underlying mechanisms during vascular injury are still unknown.
Methods and results Aneointimal formation rat model was prepared by carotid artery injury using 2F-Forgaty.
After vascular injury, Meox1 expressions time-dependently increased during the neointima formation, with its levels concurrently increasing in the adventitia, media, and neointima.
Meox1 was highly expressed in the adventitia on the first day after vascular injury compared to the expression levels in the media.
Conversely, by the 14th day post-injury, Meox1 was extensively expressed more in the media and neointima than the adventitia.
Analogous to the change of Meox1 in injured artery, Sca-1+ progenitor cells increased in the adventitia wall in a time-dependent manner and reached peak levels on the 7th day after injury.
More importantly, this effect was abolished by Meox1 knockdown with shRNA.
The enhanced expression of SDF-1α after vascular injury was associated with the markedly enhanced expression levels of Sca1+ progenitor cell, and these levels were relatively synchronously increased within neointima by the 7th day after vascular injury.
These special effects were abolished by the knockdown of Meox1 with shRNA and inhibition of CXCR4 by its inhibitor, AMD3100.
Finally, Meox1 concurrently regulated SDF-1α expressions in VSMC via activating CDC42, and CDC42 inhibition abolished these effects by its inhibitor, ZCL278.
Also, Meox1 was involved in activation of the CXCR4 expression of Sca-1+ progenitor cells by CDC42.
Conclusions Spatio-temporal model of Meox1 expression regulates theSca-1+progenitor cell migration during the formation of the neointima through the synergistic effect of Rho/CDC42 and SDF-1α/CXCR4.

Related Results

North Syrian Mortaria and Other Late Roman Personal and Utility Objects Bearing Inscriptions of Good Luck
North Syrian Mortaria and Other Late Roman Personal and Utility Objects Bearing Inscriptions of Good Luck
<span style="font-size: 11pt; color: black; font-family: 'Times New Roman','serif'">&Pi;&Eta;&Lambda;&Iota;&Nu;&Alpha; &Iota;&Gamma;&Delta...
Detectability of an intermediate layer by magnetotelluric sounding
Detectability of an intermediate layer by magnetotelluric sounding
Abstract The recent publication by Verma and Mallick (1979) on the detectability of an intermediate layer by time domain EM sounding provides some informative ans...
CXCR4 expression in feline mammary carcinoma cells: evidence of a proliferative role for the SDF-1/CXCR4 axis
CXCR4 expression in feline mammary carcinoma cells: evidence of a proliferative role for the SDF-1/CXCR4 axis
AbstractBackgroundMammary tumours frequently develop in female domestic cats being highly malignant in a large percentage of cases. Chemokines regulate many physiological and patho...
Caractérisation génomique des mutations du gène CXCR4 dans la maladie de Waldenstrom
Caractérisation génomique des mutations du gène CXCR4 dans la maladie de Waldenstrom
Contexte: La maladie de Waldenstrom (MW) est un syndrome lymphoprolifératif B caractérisé par une infiltration de la moelle osseuse par des lymphoplasmocytes et un pic monoclonal d...
CXCR4 Inhibition as a Therapeutic Strategy in Leukemia.
CXCR4 Inhibition as a Therapeutic Strategy in Leukemia.
Abstract The chemokine receptor CXCR4 is critically involved in the migration of hematopoietic cells to the stroma derived factor (SDF-1α)-producing bone marrow micr...
Role of the Chemokine Receptor CXCR4 in Waldenstrom Macroglobulinemia.
Role of the Chemokine Receptor CXCR4 in Waldenstrom Macroglobulinemia.
Abstract Waldenstrom Macroglobulinemia (WM) is characterized by the presence of lymphoplasmacytic cells in the bone marrow, and often in the lymph nodes. The mechani...
The Role of the CXCR4 Inhibitor AMD3100 in Multiple Myeloma (MM).
The Role of the CXCR4 Inhibitor AMD3100 in Multiple Myeloma (MM).
Abstract We have previously demonstrated that the chemokine receptor CXCR4 and its ligand SDF-1 are important regulators of migration in MM. The objective of this st...

Back to Top